| Autor: |
Kisner, Daniel L., Mehta, Persis, Paget, G. Edward, Hoff, Daniel D. |
| Zdroj: |
Investigational New Drugs; March 1984, Vol. 2 Issue: 1 p55-58, 4p |
| Abstrakt: |
The antitumor activity of Carbetimer was tested against 171 patient's tumors in a human tumor cloning system. Sixty-seven tumor specimens had adequate growth to be considered evaluable. In 21 specimens survival of tumor colony forming units was =50% that in control plates. Antitumor effect was most impressive in carcinomas of the breast, ovary, and lung. This information will be useful in planning disease oriented Phase II trials. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Full text from SpringerLink